Research identifies key factors in initiating tumor dormancy

Women tended to reap greater weight loss from tirzepatide (Zepbound), a subgroup analysis of the SURMOUNT trials found. Across all studies and doses, females lost

The year of an­ti­body-drug con­ju­gates isn’t done yet, as GSK is adding an­oth­er li­cens­ing part­ner­ship with Han­soh Phar­ma for an­oth­er ADC with an up­front pay­ment

No­var­tis is buy­ing gene ther­a­py and neu­ro­science biotech Kate Ther­a­peu­tics in a deal worth $1.1 bil­lion in up­front and mile­stone pay­ments, the Swiss phar­ma con­firmed